IFBC was mandated by the boards of directors of Burkhalter and Poenina to prepare a Fairness Opinion in accordance with the Merger Act assessing the share exchange ratio of the planned merger between Burkhalter Holding Ltd and poenina holding ltd from a financial point of view.
The Burkhalter Group is the leading provider of electrical engineering services to the construction sector and, with almost 50 Group companies, is represented at more than 100 locations in Switzerland. The Group is headquartered in Zurich and employs more than 3’000 people. Burkhalter Holding AG is listed on the SIX Swiss Exchange and has a market capitalization of approximately CHF 400 million.
Poenina is a leading provider of services in the areas of building technology and building envelopes and is represented by 29 companies at 42 locations in Switzerland and the Principality of Liechtenstein. The headquarters are located in Opfikon (ZH). Poenina employs almost 1’500 people. poenina holding ltd is listed on the SIX Swiss Exchange and has a market capitalization of approximately CHF 280 million.
Montana Aerospace AG carried out a capital increase by means of a private placement of new shares in November 2021. Part of the capital increase was the conversion of an existing hybrid loan into equity. IFBC was mandated by Montana Aerospace AG to prepare a fairness opinion as an independent valuation expert regarding the fair value of this hybrid loan for the attention of the Board of Directors.
Montana Aerospace AG is a leading manufacturer of system components and complex assemblies for the aerospace industry with approximately 5’300 employees. The products of Montana Aerospace AG are produced at 28 locations on four continents and are used in the aerospace, e-mobility, and energy sectors. Montana Aerospace AG is listed on the SIX Swiss Exchange.
IFBC prepared a valuation report for the attention of the board of directors of the Talenthouse Group within its IPO on SIX Swiss Exchange by the means of a reverse takeover of New Value AG. In the valuation report, group companies in Europe as well as IP rights were valued based on the sum-of-the-parts approach. The valuation report served the board of directors as a basis for decisions on further steps in the context of the reverse takeover respectively the IPO. After the reverse takeover, New Value AG decided to change its name to Talenthouse AG.
Talenthouse Group is a media and technology platform that, thanks to its global community of creatives, provides its clients (many well-known international brands and artists) with digital content. It also includes a collaborative innovation platform that helps companies from different industries to work with creatives from the various areas. It further includes an international media group that produces, manages, sells and licenses cross-media content for children and young adults.
In the context of the potential spin-off of the Lehrmittelverlag Zürich (LMVZ) from the cantonal administration into a legally independent entity, IFBC was mandated to support the LMVZ in establishing a business case tailored to this purpose. Together with the management, IFBC developed a new qualitative business plan as well as an adapted quantitative financial plan. The results served the department of education as a decision basis for further planning steps.
Lehrmittelverlag Zürich (LMVZ) is the leading provider of learning media in Switzerland. As a largely independently operating entity of the department of education of the Canton of Zurich, LMVZ employs around 65 people and holds a range of over 2,000 articles, consisting of proprietary products and merchandise. The publishing house’s educational products have won several awards for their quality and innovation.
IFBC was mandated by the board of directors of Vifor Pharma to prepare a Fairness Opinion assessing the public takeover offer made by CSL Behring AG from a financial point of view. As a qualified evaluator pursuant to Article 30(6) Takeover Ordinance, IFBC is suitably qualified to prepare Fairness Opinions.
Vifor Pharma is a globally active Swiss pharmaceutical company listed on the SIX Swiss Exchange. The company focuses on the development, manufacturing and marketing of pharmaceutical products in the areas of iron deficiency, nephrology and cardio-renal therapies.
On November 2, 2021, media service provider Annex Werbe AG and digital marketing agency adisfaction Suisse AG announced their merger to form Adisfaction-Annex AG as of January 1, 2022.
IFBC supported the two companies Annex Werbe AG and adisfaction Suisse AG as financial advisor in the evaluation of strategic alternatives, in the decision-making process as a basis for the merger, in the subsequent structuring as well as in the implementation of the merger. In addition, IFBC supported Marco Pfister in the management buyout at Annex Werbe AG as financial advisor. This included the support of the negotiations, the structuring of the financing as well as other financial aspects of the transaction.
As an agency for digital marketing and cross-media campaigns, Adisfaction-Annex AG offers its clients customized solutions from a single source.
On November 2, 2021, the Deutsche Vermögensberatung AG and Global Sana AG announced the start of a strategic partnership. IFBC supported the shareholders of Global Sana as exclusive financial and M&A advisor in the preparation of the transaction and throughout the entire transaction process. During the preparation phase of the transaction, IFBC advised the shareholders in the context of the evaluation of possible strategic options and prepared the company for the upcoming transaction in an initial transaction readiness phase. In the subsequent transaction execution, IFBC conducted a structured international buyer approach, developed the transaction structure, supported the due diligence and led the negotiations.
Global Sana is a Swiss company and with more than 110’000 customers a leading provider of insurance advisory services.
IFBC was mandated by the board of directors of Cassiopea to prepare a Fairness Opinion assessing the public exchange offer made by Cosmo Pharmaceuticals NV from a financial point of view. As a qualified evaluator pursuant to Article 30(6) Takeover Ordinance, IFBC is suitably qualified to prepare Fairness Opinions.
Cassiopea S.p.A. is an Italian specialty pharmaceutical company listed on the SIX Swiss Exchange focusing on the development and commercialization of innovative prescription drugs for the treatment of highly prevalent skin diseases.
IFBC supported the company as a financial advisor during the entire financing process, including the development of the financing concept, the negotiations with potential investors and finally the successful closing of the credit facilities and the bond issuance.
As a private group of companies with over 125 years of tradition, WWZ reliably supplies the population and economy in the canton of Zug and surrounding regions with energy, telecommunications, water and e-mobility.
IFBC was mandated by Groupe E to perform a valuation of EW Goms to assess the financial conditions of the planned capital increase. The valuation was performed by applying the sum-of-the-parts approach.
Groupe E is a leading Swiss energy company that offers a wide range of energy products and services in different areas together with the companies in the group.
In late March 2021, the Swiss affiliate of the global pharmaceutical company Takeda successfully divested part of its home delivery business to a Swiss partner who will provide these services on behalf of Takeda in the future. The divestment also included an existing Pharmacy serving part of a German-speaking region of Switzerland.
IFBC acted as exclusive M&A advisor to Takeda during the entire transaction process. IFBC supported Takeda in preparing and structuring the transaction, conducted a meaningful buyer approach, coordinated the due diligence, and supported the contract negotiations.
Takeda is a global, R&D-driven biopharmaceutical leader headquartered in Japan. Takeda focuses on four therapeutic areas: oncology, rare genetic and hematology, neuroscience, and gastroenterology. Over 50’000 Takeda employees are committed to improving quality of life for patients and to working with partners in health care in more than 70 countries.
IFBC was engaged by EnAlpin AG to review the methodological correctness of the profitability tool for assessing investments in the solar and heat contracting business and the assumed cost of capital.
EnAlpin AG, headquartered in Visp, is company with its own power plants and participations. The company is part of the Energiedienst Group (Energiedienst Holding AG) and covers the Swiss market with a focus on the canton of Valais.